HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oncology Imaging

This article was originally published in The Gray Sheet

Executive Summary

Interagency Council on Biomedical Imaging in Oncology, including representatives from FDA, the Health Care Financing Administration, and the National Institutes of Health's National Cancer Institute, will hold its next meeting Nov. 20, NIH says. The multi-agency group, which had its inaugural meeting in July as a sounding board for advice to investigators and manufacturers seeking to market new imaging technology, is accepting requests to be heard until Oct. 9. The council had reviewed 18 requests from large and small firms, as well as from members of academia. The meeting is closed to the public
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT013792

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel